TrialEye (London, England)2022

Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a Prospective Randomized Controlled Study.

Gabriella Ricciardelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.